We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




5-Minute Multiplex PCR Testing System to Redefine Point-Of-Care Diagnostics

By LabMedica International staff writers
Posted on 06 Aug 2024
Print article
Image: The LEX 5-minute diagnostics platform provides an answer faster and with less hands-on effort than any existing product on the market (Photo courtesy of LEX Diagnostics)
Image: The LEX 5-minute diagnostics platform provides an answer faster and with less hands-on effort than any existing product on the market (Photo courtesy of LEX Diagnostics)

Point of care (POC) testing provides significant clinical benefits, particularly when results can be obtained quickly enough to inform clinical decisions during a single consultation, eliminating the need for follow-up visits. Such rapid diagnostics can significantly reduce costs by minimizing both the number of patient-clinician interactions required for diagnosis and treatment decisions and the need for patients to make multiple trips to the healthcare facility for a single episode of illness. Typically, POC molecular diagnostic tests can produce results within about an hour. Now, a low-cost instrument aims to redefine POC diagnostics by delivering molecular tests at the time they are most needed.

LEX Diagnostics (Melbourn, UK) is developing a PCR molecular system that offers both high speed and high sensitivity, capable of completing a test in less than 10 minutes and reporting positive results in as little as 5 minutes. This ensures that results are available quickly enough to impact clinical decisions within the same appointment. The LEX system is designed around a cartridge that receives a dry swab and conducts all necessary sample preparation, processing, and analysis internally, without the need for manual sample elution or other preparatory steps. This design not only speeds up the process but also confines all sample handling within the system, reducing the manual effort required and minimizing the exposure risk for healthcare workers.

The device's ability to provide rapid yet sensitive PCR testing is facilitated by innovative thermal cycling technology and proprietary LEX reagents. Unlike traditional systems that rely on Peltier devices, which can be costly and less reliable, LEX’s patented thermal cycler technology allows for extremely quick heating and cooling, maintaining precise thermal control. This capability ensures that enzyme-driven amplification processes are optimized for speed without sacrificing sensitivity, making rapid PCR diagnostics feasible at the POC. The LEX system is suitable for settings with a CLIA waiver, including urgent care centers, pharmacies, and physician offices.

The LEX system is capable of delivering positive results in just 5 minutes and can perform multiplex testing to identify and differentiate between Flu A, Flu B, and COVID-19. Negative results are delivered in under 10 minutes. LEX is also planning to expand its range of respiratory tests to include rapid assays for RSV and Strep A, which are expected to be completed in about 5 minutes. With the development of its second-generation instrument, LEX aims to add testing for sexually transmitted infections (STIs) to its portfolio.

Related Links:
LEX Diagnostics

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Drug Detection Platform
ABSOLUDY Drug Detection Platform
New
Metabolic Disorder Test
LIAISON Bone & Mineral Diagnostic Solution

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: The Accelerate WAVE system delivers rapid AST directly from positive blood culture bottles (Photo courtesy of Accelerate Diagnostics)

Rapid Diagnostic System to Deliver Same-Shift Antibiotic Susceptibility Test Results

The World Health Organization estimates that sepsis impacts around 49 million people worldwide each year, resulting in roughly 11 million deaths, with about 1.32 million of these deaths directly linked... Read more

Pathology

view channel
Image: Steps and methodology of skin biopsy processing for dSTORM (Photo courtesy of Front. Mol. Neurosci. (2024); DOI: 10.3389/fnmol.2024.1431549)

Super-Resolution Imaging Detects Parkinson's 20 Years Before First Motor Symptoms Appear

Parkinson's disease is the second most common neurodegenerative disorder globally, affecting approximately 8.5 million people today. This debilitating condition is characterized by the destruction of ... Read more

Industry

view channel
Image: The Scopio X100 and X100HT full-field digital cell morphology solution (Photo courtesy of Beckman Coulter)

Beckman Coulter and Scopio Labs Add World's First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership

Since 2022, Beckman Coulter (Brea, CA, USA) and Scopio Labs (Tel Aviv, Israel) have been working together to accelerate adoption of the next generation of digital cell morphology. Scopio's X100 and X100HT... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.